The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding ...
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The Quality Pathway can drive greater care improvements through the use of multiple complementary levers of change, such as ...
Of the scores of day-one executive orders (EOs) issued by President Trump, the order rescinding a Biden administration executive order on ...
Former President Biden had directed the Center for Medicare and Medicaid Innovation, an arm of the Centers for Medicare and Medicaid Services, to look into ways to make prescription drugs cheaper ...
The Center for Medicare and Medicaid Innovation had started the process of enrolling states in the pilot program, and the application process was expected to be open through Feb. 28. Read ...
The Centers for Medicare & Medicaid Services (CMS ... This expansion continues a flawed policy that threatens innovation and jeopardizes patient access to critical treatments, including drugs ...
The U.S. Centers for Medicare and Medicaid Services released its list of drugs covered under Medicare Part D selected for the ...
President Trump rescinded an executive order that prompted the creation of three Medicare drug-pricing experiments ...
Among the many rescissions of Biden administration Executive Orders, signed by President Trump on his administration’s first ...
The agency’s innovation center could test an alternative policy ... Her portfolio included steering legislation that affected Medicaid and Medicare Advantage — an offshoot of traditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback